GlobeNewswire by notified

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hildén

Dela

Företagsmeddelande, Helsingfors, 14.4.2022 kl. 15.00(EEST)

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hildén

Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) meddelar av följande transaktioner utförda av personer i ledande ställning:

Den anmälningsskyldiga
Nam: Timo Hildén
Befattning: Styrelseledamot/suppleant

Emittent: Nexstim Oyj
LEI: 743700S7ZI0LNMHZ6Y27
Anmälans karaktär: FÖRSTA ANMÄLAN
Referensnummer: 13303/7/6
____________________________________________

Transaktionens datum: 2022-04-13
Handelsplats: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Typ av instrument: AKTIE
ISIN: FI4000506811
Transaktionens karaktär: MOTTAGANDE AV AKTIEBONUS ELLER AKTIEARVODE
(X) Transaktionen är kopplad till utförandet av ett aktieoptionsprogram

Detaljer om transaktionerna
(1): Volym: 1512 Enhetspris: 0 EUR

Aggregerad information om transaktionerna
(1): Volym: 1512 Medelpris: 0 EUR

För mer information gå in på bolagets webbplats på www.nexstim.com eller kontakta:

Mikko Karvinen, verkställande direktör
+358 50 326 4101
mikko.karvinen@nexstim.com

Erik Penser Bank AB (certified adviser)
+46 8 463 83 00
certifiedadviser@penser.se

Om Nexstim Abp

Nexstim är ett finländskt tillväxtorienterat medicinteknikbolag som verkar på den globala marknaden. Vår mission är att möjliggöra individualiserad och effektiv diagnostik och behandling av svåra sjukdomar i hjärnan.

Nexstim har tagit fram en banbrytande teknik för icke-invasiv hjärnstimulering som bygger på transkraniell magnetstimulering (TMS) i kombination med 3D-navigering. Den unika tekniken möjliggör exakt och individuellt anpassad stimulering av det rätta området i hjärnan.

Affärsområdet diagnostik arbetar med kommersialisering av Nexstims NBS-system för navigerad hjärnstimulering (Navigated Brain Stimulation). NBS-systemet är det enda FDA-godkända och CE-märkta TMS-systemet för preoperativ kartläggning av hjärnbarken för motorik och tal.

Affärsområdet terapi marknadsför och säljer Nexstims NBT®-system för navigerad hjärnterapi (Navigated Brain Therapy), som fått godkännande från FDA för marknadsföring och försäljning i USA för behandling av egentlig depression. NBT®-systemet har i Europa fått CE-märkning för behandling av egentlig depression och kronisk neuropatisk smärta.

Nexstims aktier är noterade på Nasdaq First North Growth Market Finland och Nasdaq First North Growth Market Sweden.

Mer information finns på www.nexstim.com

Bilaga

För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.
För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.

Om

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire by notified

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire by notified

ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update17.5.2022 07:00:00 CEST | Press release

-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis: Reported positive topline results for linzagolix 200 mg with add-back therapy in the Phase 3 EDELWEISS 3 trial- -Linzagolix franchise: Announced licensing agreement with Theramex to support commercialization in Europe, in addition to relationship with Syneos Health to support commercialization in the United States- Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland– May17, 2022 – ObsEva SA (NASDAQ: OBSV)(SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported financial results for the first quarter ended March 31, 2022 and provided a business update. “We are eagerly anticipating the approval of linzagolix in Europe, which would mark our first product approval and a major achi

Arcadis partners with Shenzhen Bus Group to collaborate on Fleet Electrification Transition Services in Australia17.5.2022 07:00:00 CEST | Press release

17 May, 2022 – Arcadis (EURONEXT: ARCAD), the leading global design and consultancy organization for natural and built assets, and Shenzhen Bus Group (Shenzhen Bus), the world's first and largest pure electric public transportation group, have combined their expertise to provide joint advisory services specifically related to the transition to electric bus fleets for Australian government authorities and companies. Shenzhen Bus brings a wealth of operational expertise to the partnership, having electrified its own fleet of over 11,000 vehicles. This experience, combined with Arcadis' knowledge of urbanization, connected and thriving cities, climate change and digitalization, will help customers accelerate the electrification of their fleets. Greg Steele, Global President, Mobility at Arcadis said: “Bringing together the expertise of Arcadis and Shenzhen Bus Group to support the transition of fleets is truly market changing. Together, we can provide innovative and timely solutions for f

Clariant updates Financial Calendar – Governance Agreement with SABIC to expire after AGM on 24 June 202217.5.2022 07:00:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR MUTTENZ, MAY17, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today announced that it has scheduled its Annual General Meeting (AGM) for 24 June 2022, and that with the closing of the AGM the Governance Agreement between Clariant and SABIC will expire. Both parties entered into the agreement on 17 September 2018 when SABIC became Clariant’s anchor shareholder (see 2018 Media Release: Clariant and SABIC enter Governance agreement defining the long-term strategic relationship). As a result of the expiry of the agreement after the AGM 2022, Clariant and SABIC will no longer form a Group regarding the attribution of voting rights and regulatory requirements pursuant to article 120 of the Financial Market Infrastructure Act (FinMIA). “The Board will continue to drive Clariant’s purpose-led strategy together with the Executive Management Team, with a focus on customer, innovation, sustainability, and people to del

Cool Company Ltd. – Q1 2022 Business Update call16.5.2022 23:04:27 CEST | Press release

Cool Company Ltd will hold a Q1 2022 business update call for investors at 10am Oslo time on Tuesday May 31. Prior to the start of the call a presentation will be made available in the Investors section of the Cool Company Ltd. website www.coolcoltd.com We recommend that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call dial-in information below. Please dial in 10 minutes prior to the start time to allow time for call handling. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions per participant. a. Listen-only live webcastlink Go to the Investors section at www.coolcoltd.com and click on the link to "Webcast". To listen to the conference call from the web, you need to have installed Windows Media Player, and you

Golar releases its 2021 Environmental, Social and Governance report16.5.2022 22:53:05 CEST | Press release

Golar LNG Limited (“Golar”) is pleased to announce that it has issued its 2021 Environmental, Social and Governance (“ESG”) report. This comprehensive report describes Golar’s important role in advancing the global energy transition to a lower carbon future - championing LNG as a transition fuel in partnership with renewables, and as a reliable alternative for those in need of energy security today. As part of our target to further reduce emissions from our operations Golar has invested in a carbon capture technology company that has developed and achieved proof of concept for a CO2 capture and separation membrane technology. Subject to successful completion of a commercial pilot project with another industrial user, the technology could be used in future FLNG projects. Our 2021 ESG report is attached and will also be posted to our website. Forward-Looking Statements This press release contains forward-looking statements (as defined in Section 21E of the Securities Exchange Act of 1934